PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review
Year: 2018
Type: review
Authors: Yehuda Handelsman, Norman E. Lepor
Institution: Cedars-Sinai Smidt Heart Institute
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,810
Funders: Sanofi, Regeneron Pharmaceuticals
OpenAlex ID: W2808977553
